A controlled trial of adaptive disclosure-enhanced to improve functioning and treat posttraumatic stress disorder.

ABSTRACT:

Objective

This is a randomized controlled trial (NCT03056157) of an enhanced adaptive disclosure (AD) psychotherapy compared to present-centered therapy (PCT; each 12 sessions) in 174 veterans with posttraumatic stress disorder (PTSD) related to traumatic loss (TL) and moral injury (MI). AD employs different strategies for different trauma types. AD-Enhanced (AD-E) uses letter writing (e.g., to the deceased), loving-kindness meditation, and bolstered homework to facilitate improved functioning to repair TL and MI-related trauma.

Method

The primary outcomes were the Sheehan Disability Scale (SDS), evaluated at baseline, throughout treatment, and at 3- and 6-month follow-ups (Brief Inventory of Psychosocial Functioning was also administered), the Clinician-Administered PTSD Sc

SUBMITTER: Litz BT 

PROVIDER: S-EPMC11771448 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature